Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 2
1990 1
1994 2
1995 2
1996 1
1997 3
1999 2
2000 7
2001 20
2002 34
2003 40
2004 51
2005 47
2006 47
2007 43
2008 36
2009 50
2010 24
2011 36
2012 24
2013 40
2014 29
2015 30
2016 24
2017 31
2018 23
2019 31
2020 40
2021 34
2022 18
2023 24
2024 22

Text availability

Article attribute

Article type

Publication date

Search Results

740 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for neoclarityn
Your search for neoclarityne retrieved no results
Allergic Rhinitis: A Review.
Bernstein JA, Bernstein JS, Makol R, Ward S. Bernstein JA, et al. JAMA. 2024 Mar 12;331(10):866-877. doi: 10.1001/jama.2024.0530. JAMA. 2024. PMID: 38470381 Review.
In addition, first-line treatment for mild intermittent or mild persistent allergic rhinitis may include a second-generation H1 antihistamine (eg, cetirizine, fexofenadine, desloratadine, loratadine) or an intranasal antihistamine (eg, azelastine, olopatadine), whereas pat …
In addition, first-line treatment for mild intermittent or mild persistent allergic rhinitis may include a second-generation H1 antihistamin …
Pharmacology of antihistamines.
Church MK, Church DS. Church MK, et al. Indian J Dermatol. 2013 May;58(3):219-24. doi: 10.4103/0019-5154.110832. Indian J Dermatol. 2013. PMID: 23723474 Free PMC article.
Three drugs widely used for symptomatic relief in urticaria, desloratadine, levocetirizine and fexofenadine are highlighted in this review. ...However, levocetirizine may cause somnolence in susceptible individuals, whereas fexofenadine has a relatively short duration of a …
Three drugs widely used for symptomatic relief in urticaria, desloratadine, levocetirizine and fexofenadine are highlighted in this r …
Desloratadine.
[No authors listed] [No authors listed] 2021 Sep 20. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2021 Sep 20. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000785 Free Books & Documents. Review.
Because of its expected low milk levels and lack of sedation and anticholinergic effects, maternal use of desloratadine is unlikely to affect a breastfed infant or milk production. Desloratadine might have a negative effect on lactation in combination with a sympath …
Because of its expected low milk levels and lack of sedation and anticholinergic effects, maternal use of desloratadine is unlikely t …
EDITORIAL.
Kennedy DW. Kennedy DW. Int Forum Allergy Rhinol. 2015 Dec;5(12):1083-4. doi: 10.1002/alr.21692. Int Forum Allergy Rhinol. 2015. PMID: 26769189 No abstract available.
H1-antihistamines for chronic spontaneous urticaria.
Sharma M, Bennett C, Cohen SN, Carter B. Sharma M, et al. Cochrane Database Syst Rev. 2014 Nov 14;2014(11):CD006137. doi: 10.1002/14651858.CD006137.pub2. Cochrane Database Syst Rev. 2014. PMID: 25397904 Free PMC article. Review.
The duration of the intervention was up to two weeks (short-term) or longer than two weeks and up to three months (intermediate-term).Cetirizine 10mg once daily in the short term and in the intermediate term led to complete suppression of urticaria by more participants than was s …
The duration of the intervention was up to two weeks (short-term) or longer than two weeks and up to three months (intermediate-term).Cetiri …
Blockade of NMT1 enzymatic activity inhibits N-myristoylation of VILIP3 protein and suppresses liver cancer progression.
Tan XP, He Y, Yang J, Wei X, Fan YL, Zhang GG, Zhu YD, Li ZQ, Liao HX, Qin DJ, Guan XY, Li B. Tan XP, et al. Signal Transduct Target Ther. 2023 Jan 9;8(1):14. doi: 10.1038/s41392-022-01248-9. Signal Transduct Target Ther. 2023. PMID: 36617552 Free PMC article.
N-myristoyl transferase 1 (NMT1) was identified as a target protein of desloratadine by drug affinity responsive target stability (DARTS) and surface plasmon resonance (SPR) assays. ...Conclusively, this study demonstrates that desloratadine may be a novel anticance …
N-myristoyl transferase 1 (NMT1) was identified as a target protein of desloratadine by drug affinity responsive target stability (DA …
Clinical pharmacokinetics and pharmacodynamics of desloratadine, fexofenadine and levocetirizine : a comparative review.
Devillier P, Roche N, Faisy C. Devillier P, et al. Clin Pharmacokinet. 2008;47(4):217-30. doi: 10.2165/00003088-200847040-00001. Clin Pharmacokinet. 2008. PMID: 18336052 Review.
No major cytochrome P450 inhibition has been reported with desloratadine, fexofenadine and levocetirizine, and the bioavailability of desloratadine is minimally affected by drugs interfering with transporter molecules. Of the second-generation antihistamines, des …
No major cytochrome P450 inhibition has been reported with desloratadine, fexofenadine and levocetirizine, and the bioavailability of …
Efficacy and Safety of Up-dosed Second-generation Antihistamines in Uncontrolled Chronic Spontaneous Urticaria: A Review.
Podder I, Dhabal A, Chakraborty SS. Podder I, et al. J Clin Aesthet Dermatol. 2023 Mar;16(3):44-50. J Clin Aesthet Dermatol. 2023. PMID: 36950042 Free PMC article. Review.
METHODS: We conducted a comprehensive search of the literature across multiple databases (PubMed, EMBASE, MEDLINE and Google scholar) using the keywords (alone and in combination) and MeSH items as well as non-MeSH terms such as "chronic spontaneous urticaria", "chronic idiopathi …
METHODS: We conducted a comprehensive search of the literature across multiple databases (PubMed, EMBASE, MEDLINE and Google scholar) using …
Reply.
Trautmann A, Stoevesandt J. Trautmann A, et al. J Allergy Clin Immunol Pract. 2017 Mar-Apr;5(2):535-536. doi: 10.1016/j.jaip.2016.12.020. J Allergy Clin Immunol Pract. 2017. PMID: 28283170 No abstract available.
Desloratadine.
McClellan K, Jarvis B. McClellan K, et al. Drugs. 2001;61(6):789-96; discussion 797. doi: 10.2165/00003495-200161060-00007. Drugs. 2001. PMID: 11398910
Desloratadine is the orally active major metabolite of the nonsedating H1-antihistamine loratadine. ...No clinically significant interactions have been reported between desloratadine and drugs that inhibit the cytochrome P450 system, nor does the drug potentiate the …
Desloratadine is the orally active major metabolite of the nonsedating H1-antihistamine loratadine. ...No clinically significant inte …
740 results